Latest NewsOct 7, 2024HiFiBiO Therapeutics to Showcase DIS® Enabled Translational Insights from Ongoing Phase 1 Clinical Trials for Two Novel Immuno-Oncology Antibodies at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)All Filter By: Year2024202320222021202020192018201720162015May 26, 2016HiFiBiO receives recognition as one of Biocentury InnovationsMay 16, 2016HiFiBiO SAS announces participation in next generation antibody therapeutics session along with Adimab, F-Star and Innovative Targeting Solutions at BioInternational 2016 in San Francisco, USAMar 23, 2016HiFiBiO is Recognized as an “Innovative Start-up Company” by French President Francois Hollande at the Inauguration of the Institute Pierre-Gilles de GennesNov 23, 2015HiFiBiO SAS to Report Results from the First Fully Integrated, Single-Cell Antibody Discovery Platform at IBC Antibody and Engineering Therapeutics 2015 ConferenceOct 27, 2015HiFiBiO’s next generation antibody discovery platform to be presented by Pfizer Inc. at PEGS Europe 2015< 1 … 14 15 16 17 >